| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC | Director | Common Stock | 11,206 | $70,597 | $6.30 | 15 Dec 2025 | Direct |
| GALECTIN THERAPEUTICS INC | Director | Stock option (right to buy) | 60,000 | 16 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GALT | GALECTIN THERAPEUTICS INC | 16 Jan 2026 | 1 | $0 | 4 | Director | 21 Jan 2026, 16:46 |
| GALT | GALECTIN THERAPEUTICS INC | 17 Dec 2025 | 4 | -$132,824 | 4 | Director | 19 Dec 2025, 16:05 |
| GALT | GALECTIN THERAPEUTICS INC | 12 Dec 2025 | 6 | -$59,855 | 4 | Director | 16 Dec 2025, 16:22 |
| GALT | GALECTIN THERAPEUTICS INC | 08 Dec 2025 | 22 | -$664,515 | 4 | Director | 10 Dec 2025, 08:15 |
| GALT | GALECTIN THERAPEUTICS INC | 23 Jan 2025 | 1 | $0 | 4 | Director | 30 Jan 2025, 12:40 |
| GALT | GALECTIN THERAPEUTICS INC | 30 Dec 2024 | 1 | +$7,540 | 4 | Director | 31 Dec 2024, 07:45 |
| GALT | GALECTIN THERAPEUTICS INC | 26 Jan 2023 | 1 | $0 | 4 | Director | 30 Jan 2023, 15:50 |
| GALT | GALECTIN THERAPEUTICS INC | 24 Jan 2022 | 1 | $0 | 4 | Director | 25 Jan 2022, 15:52 |